Evaluation of Immunomodulatory Treatment Based on Conventional and Lineage-Specific Chimerism Analysis in Patients With Myeloid Malignancies After Myeloablative Allogeneic Hematopoietic Cell Transplantation
Leukemia - United Kingdom
doi 10.1038/sj.leu.2403719
Full Text
Open PDFAbstract
Available in full text
Date
March 17, 2005
Authors
Publisher
Springer Science and Business Media LLC